FDA Webview
X

Free FDA Notices

Pediatric Panel to Discuss Obesity, Puberty Disorders

10/07/2005

Federal Register Notice: FDA’s Pediatric Advisory Committee will meet 11/16, from 8 a.m. to 6 p.m., and 11/17, from 8 a.m. to 5 p.m. at the Washington DC North/Gaithersburg Hilton, 620 Perry Pkwy., Gaithersburg, MD. On 11/16, the committee will hear and discuss the recommendation of the Pediatric Ethics Subcommittee from its 11/15 meeting on a proposed pediatric study of a GnRH agonist test in puberty disorders. The committee will also discuss pediatric obesity and clinical trial designs for evaluating devices intended for treatment. On 11/17, the committee will continue its discussion of clinical trials and evaluation of devices intended to treat pediatric obesity. Contact Jan N. Johannessen, (301) 827-6687. To view this notice, click here.

LATEST NEWS